- SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma
Yong Liu et al, 2015, Tumor Biology CrossRef - SMYD3: a regulator of epigenetic and signaling pathways in cancer
Benjamin J. Bernard et al, 2021, Clinical Epigenetics CrossRef - Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells
Jin-Man Kim et al, 2015, Nucleic Acids Research CrossRef - Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents
Gurukumari Rajajeyabalachandran et al, 2017, Expert Opinion on Therapeutic Targets CrossRef - PRDI-BF1-RIZ domain of retinoblastoma protein-interacting zinc finger gene 1 induces apoptosis and exerts anticancer activity in esophageal squamous cell carcinoma cells
SHANG-WEN DONG et al, 2015, Oncology Letters CrossRef - Playing on the Dark Side: SMYD3 Acts as a Cancer Genome Keeper in Gastrointestinal Malignancies
Paola Sanese et al, 2021, Cancers CrossRef - Protein Lysine Methyltransferases Inhibitors
Ying Li et al, 2023, Current Medicinal Chemistry CrossRef - Role of several histone lysine methyltransferases in tumor development
JIFU LI et al, 2016, Biomedical Reports CrossRef - SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma
Liangliang Xu et al, 2019, Clinical Science CrossRef - Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes
Nair Lopes et al, 2020, International Journal of Molecular Sciences CrossRef - Structure and Function of SET and MYND Domain-Containing Proteins
Nicholas Spellmon et al, 2015, International Journal of Molecular Sciences CrossRef - Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
Michael J. Thomenius et al, 2018, PLOS ONE CrossRef - SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
Cinzia Bottino et al, 2020, Cancers CrossRef - SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma
Ying Zhu et al, 2016, Human Pathology CrossRef - SMYD Protein Family as Promising Biomarkers for Cancer Diagnosis and Prognosis
Yingxue Zhang et al, 2022, Genomic and Epigenomic Biomarkers of Toxicology and Disease CrossRef - A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinoma
YANAN JIANG et al, 2016, Oncology Reports CrossRef - The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance
Catarina Macedo-Silva et al, 2019, Genes CrossRef - SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma
Swapna Asuthkar et al, 2022, Cancers CrossRef - Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2
Yu Wang et al, 2019, Oncogene CrossRef - Critical roles of non-histone protein lysine methylation in human tumorigenesis
Ryuji Hamamoto et al, 2015, Nature Reviews Cancer CrossRef - Small-molecule Inhibitors of Lysine Methyltransferases SMYD2 and SMYD3: Current Trends
Edoardo Fabini et al, 2019, Future Medicinal Chemistry CrossRef - Epigenetic modifications and regulations in gastrointestinal diseases
Aditi Bhattacharya, 2023, Epigenetics in Organ Specific Disorders CrossRef